Literature DB >> 30508240

Dermatomyositis: a slow path towards targeted therapies or will conventional therapies prevail?

V Piguet1,2,3, E Choy4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30508240     DOI： 10.1111/bjd.16230

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  1 in total

Review 1.  The validity and utility of the Cutaneous Disease Area and Severity Index (CDASI) as a clinical outcome instrument in dermatomyositis: A comprehensive review.

Authors:  S Ahmed; K L Chen; V P Werth
Journal:  Semin Arthritis Rheum       Date:  2020-01-11       Impact factor: 5.532
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.